0001140361-24-005499.txt : 20240205
0001140361-24-005499.hdr.sgml : 20240205
20240205060151
ACCESSION NUMBER: 0001140361-24-005499
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240201
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Piekos Brian
CENTRAL INDEX KEY: 0001815308
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39990
FILM NUMBER: 24593808
MAIL ADDRESS:
STREET 1: C/O AMAG PHARMACEUTICALS, INC.
STREET 2: 1100 WINTER STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Elicio Therapeutics, Inc.
CENTRAL INDEX KEY: 0001601485
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 113430072
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: (857) 209-0050
MAIL ADDRESS:
STREET 1: 451 D STREET, 5TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER COMPANY:
FORMER CONFORMED NAME: Angion Biomedica Corp.
DATE OF NAME CHANGE: 20140228
4
1
form4.xml
FORM 4
X0508
4
2024-02-01
0001601485
Elicio Therapeutics, Inc.
ELTX
0001815308
Piekos Brian
C/O ELICIO THERAPEUTICS, INC.
451 D STREET, 5TH FLOOR, SUITE 501
BOSTON
MA
02210
true
Chief Financial Officer
false
Stock Option (right to buy)
4.5
2024-02-01
4
A
0
43225
0
A
2034-02-01
Common Stock
43225
43225
D
Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
/s/Brian Piekos
2024-02-05